Response to letters regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".
作者信息
Ghebremariam Yohannes T, Lee Jerry C, LePendu Paea, Erlanson Daniel A, Slaviero Anna, Shah Nigam H, Leiper James M, Cooke John P
机构信息
Department of Cardiovascular Sciences, Texas Methodist Hospital Research Institute, Houston, Texas.
出版信息
Circulation. 2014 Apr 1;129(13):e428. doi: 10.1161/CIRCULATIONAHA.114.009343.
Abstract
摘要
相似文献
1
Response to letters regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".对关于文章《质子泵抑制剂的意外作用：心血管危险因素不对称二甲基精氨酸升高》的信件的回复
Circulation. 2014 Apr 1;129(13):e428. doi: 10.1161/CIRCULATIONAHA.114.009343.
2
Letter by Montenegro and Lundberg regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".黑山和伦德伯格就“质子泵抑制剂的意外作用：心血管危险因素不对称二甲基精氨酸升高”一文所写的信。
Circulation. 2014 Apr 1;129(13):e426. doi: 10.1161/CIRCULATIONAHA.113.005585.
3
Letter by Pinheiro et al regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".皮涅罗等人就“质子泵抑制剂的意外作用：心血管危险因素不对称二甲基精氨酸升高”一文所写的信。
Circulation. 2014 Apr 1;129(13):e427. doi: 10.1161/CIRCULATIONAHA.113.005307.
4
Letter by Chyrchel et al regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".Chyrchel等人就题为《质子泵抑制剂的意外效应：心血管危险因素不对称二甲基精氨酸水平升高》的文章所写的信。
Circulation. 2014 Apr 1;129(13):e425. doi: 10.1161/CIRCULATIONAHA.113.006284.
5
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.质子泵抑制剂的意外作用：心血管风险因素不对称二甲基精氨酸的升高。
Circulation. 2013 Aug 20;128(8):845-53. doi: 10.1161/CIRCULATIONAHA.113.003602. Epub 2013 Jul 3.
6
Cardiovascular Risk of Proton Pump Inhibitors.质子泵抑制剂的心血管风险
Methodist Debakey Cardiovasc J. 2019 Jul-Sep;15(3):214-219. doi: 10.14797/mdcj-15-3-214.
7
Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance.质子泵抑制剂对人二甲基精氨酸二甲氨基水解酶 1 的抑制作用及心血管风险标志物不对称二甲基精氨酸：体外和体内意义。
Sci Rep. 2017 Jun 6;7(1):2871. doi: 10.1038/s41598-017-03069-1.
8
Proton pump inhibitors: seeking the golden ratio between gastroprotection and cardiovascular risk.
Eur Heart J Cardiovasc Pharmacother. 2024 Aug 14;10(5):420-421. doi: 10.1093/ehjcvp/pvae037.
9
[Refractory gastroesophageal reflux disease (GERD) and PPI safety].[难治性胃食管反流病（GERD）与质子泵抑制剂（PPI）的安全性]
Rev Gastroenterol Mex. 2013 Aug;78 Suppl 1:1-3. doi: 10.1016/j.rgmx.2013.06.016.
10
Proton pump inhibitors and Raynaud's phenomenon: is there a link?质子泵抑制剂与雷诺现象：存在关联吗？
Br J Clin Pharmacol. 2018 Oct;84(10):2443-2444. doi: 10.1111/bcp.13697. Epub 2018 Jul 12.
引用本文的文献
1
Proton pump inhibitor usage is associated with higher all-cause mortality and CV events in peritoneal dialysis patients.质子泵抑制剂的使用与腹膜透析患者的全因死亡率和心血管事件的发生相关。
Ren Fail. 2022 Dec;44(1):407-414. doi: 10.1080/0886022X.2022.2043903.
2
Possible Effects of Proton Pump Inhibitors on Hearing Loss Development.质子泵抑制剂对耳聋发展的可能影响。
Biomed Res Int. 2019 Oct 17;2019:4853695. doi: 10.1155/2019/4853695. eCollection 2019.
3
Peptic Ulcer Disease: A Brief Review of Conventional Therapy and Herbal Treatment Options.消化性溃疡病：传统疗法与草药治疗选择的简要综述
J Clin Med. 2019 Feb 3;8(2):179. doi: 10.3390/jcm8020179.
4
Proton pump inhibitors and vascular function: A prospective cross-over pilot study.质子泵抑制剂与血管功能：一项前瞻性交叉试点研究。
Vasc Med. 2015 Aug;20(4):309-16. doi: 10.1177/1358863X14568444. Epub 2015 Apr 2.
本文引用的文献
1
Letter by Chyrchel et al regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".Chyrchel等人就题为《质子泵抑制剂的意外效应：心血管危险因素不对称二甲基精氨酸水平升高》的文章所写的信。
Circulation. 2014 Apr 1;129(13):e425. doi: 10.1161/CIRCULATIONAHA.113.006284.
2
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.质子泵抑制剂的意外作用：心血管风险因素不对称二甲基精氨酸的升高。
Circulation. 2013 Aug 20;128(8):845-53. doi: 10.1161/CIRCULATIONAHA.113.003602. Epub 2013 Jul 3.
3
Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.高同型半胱氨酸血症诱导的内皮功能障碍：非对称二甲基精氨酸的作用
Circulation. 2003 Aug 26;108(8):933-8. doi: 10.1161/01.CIR.0000085067.55901.89. Epub 2003 Aug 11.
4
Vitamin B12 levels during prolonged treatment with proton pump inhibitors.质子泵抑制剂长期治疗期间的维生素B12水平
J Clin Gastroenterol. 2000 Jan;30(1):29-33. doi: 10.1097/00004836-200001000-00006.
5
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group.一项关于饮食模式对血压影响的临床试验。DASH 协作研究小组。
N Engl J Med. 1997 Apr 17;336(16):1117-24. doi: 10.1056/NEJM199704173361601.
Zotero 插件